{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:36:57Z","timestamp":1769157417409,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-182-021-MY3"],"award-info":[{"award-number":["109-2320-B-182-021-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6L0241"],"award-info":[{"award-number":["CMRPG6L0241"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG6K0211"],"award-info":[{"award-number":["CORPG6K0211"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG6K0212"],"award-info":[{"award-number":["CORPG6K0212"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e17701","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T21:32:54Z","timestamp":1688419974000},"page":"e17701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-6647","authenticated-orcid":false,"given":"Ching-Yuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8080-0504","authenticated-orcid":false,"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-5841","authenticated-orcid":false,"given":"Yu-Shih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hsin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ching","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Te","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-7628","authenticated-orcid":false,"given":"I-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4995-5364","authenticated-orcid":false,"given":"Wei-Tai","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-1119","authenticated-orcid":false,"given":"Pei-Rung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5939-9747","authenticated-orcid":false,"given":"Geng-He","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reming-Albert","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Huei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Heng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-3906","authenticated-orcid":false,"given":"Rou-Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shao","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"6485","key":"10.1016\/j.heliyon.2023.e17701_bib2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17701_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"Duffy","year":"2018","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17701_bib7","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/jmv.27717","article-title":"SARS-CoV-2 variants and vulnerability at the global level","volume":"94","author":"Chavda","year":"2022","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17701_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.heliyon.2023.e17701_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl9463","article-title":"Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant","author":"Zhang","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","article-title":"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines","volume":"54","author":"Fernandes","year":"2022","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23041987","article-title":"Omicron genetic and clinical peculiarities that may overturn SARS-CoV-2 pandemic: a literature review","volume":"23","author":"Tiecco","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e17701_bib13","article-title":"Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis","volume":"401","author":"Team","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jmv.27503","article-title":"Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: associated risk factors and preventive actions","volume":"94","author":"Daria","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2023.e17701_bib15","article-title":"Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies","volume":"12","author":"Shah","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052870","article-title":"Mutations of Omicron variant at the interface of the receptor domain motif and human angiotensin-converting enzyme-2","volume":"23","author":"Adhikari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063409","article-title":"Improved binding affinity of omicron\u2019s spike protein for the human angiotensin-converting enzyme 2 receptor is the key behind its increased virulence","volume":"23","author":"Kumar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/clinpract11040093","article-title":"Analysis of the Delta variant B.1.617.2 COVID-19","volume":"11","author":"Shiehzadegan","year":"2021","journal-title":"Clin. Pract."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e17701_bib19","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1016\/j.cell.2021.04.025","article-title":"Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant","volume":"184","author":"Deng","year":"2021","journal-title":"Cell"},{"issue":"6555","key":"10.1016\/j.heliyon.2023.e17701_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.abi7994","article-title":"SARS-CoV-2 immune evasion by the B.1.427\/B.1.429 variant of concern","volume":"373","author":"McCallum","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiab368","article-title":"SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion","volume":"224","author":"Ferreira","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e17701_bib22","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","article-title":"The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies","volume":"184","author":"Copin","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"600","key":"10.1016\/j.heliyon.2023.e17701_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiab368","article-title":"Genotype to phenotype Japan, SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion","volume":"224","author":"Ferreira","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/imt-2021-0168","article-title":"A global picture: therapeutic perspectives for COVID-19","volume":"14","author":"Chavda","year":"2022","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s40001-022-00818-5","article-title":"Traditional herbs against COVID-19: back to old weapons to combat the new pandemic","volume":"27","author":"Al-Kuraishy","year":"2022","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccmp.2022.100021","article-title":"Herbal remedies, nutraceuticals, and dietary supplements for COVID-19 management: an update","volume":"2","author":"Chavda","year":"2022","journal-title":"Clin Complement Med Pharmacol"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.900","article-title":"Use of home remedies for the treatment and prevention of coronavirus disease: an integrative review","volume":"6","author":"Malapela","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.heliyon.2023.e17701_bib30","series-title":"Supplement to Compendium of Materia Medica","author":"Xuemin","year":"1765"},{"key":"10.1016\/j.heliyon.2023.e17701_bib31","unstructured":"S. Shi, Brush Records of Chouchi, The Complete Library in Four Sections (960-1126)."},{"key":"10.1016\/j.heliyon.2023.e17701_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110816","article-title":"GB-2 inhibits ACE2 and TMPRSS2 expression: in vivo and in vitro studies","volume":"132","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e17701_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112011","article-title":"GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2","volume":"142","author":"Tsai","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/s13063-020-04634-2","article-title":"A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Khan","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s13063-020-04846-6","article-title":"Salivary and Nasal Detection of the SARS-CoV-2 Virus after Antiviral Mouthrinses (BBCovid): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Carrouel","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib36","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1038\/s41598-018-25311-0","article-title":"Quantitation of the cellular content of saliva and buccal swab samples","volume":"8","author":"Theda","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2023.e17701_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.584158","article-title":"Potential simultaneous inhibitors of angiotensin-converting enzyme 2 and transmembrane protease, serine 2","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6508","key":"10.1016\/j.heliyon.2023.e17701_bib39","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2023.e17701_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112802","article-title":"Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations","volume":"149","author":"Tsai","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e17701_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2017.08.011","article-title":"Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway","volume":"209","author":"Lin","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40360-018-0195-4","article-title":"Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway","volume":"19","author":"Lee","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib45","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17701_bib46","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/cid\/ciaa939","article-title":"It is time to address airborne transmission of coronavirus disease 2019 (COVID-19)","volume":"71","author":"Morawska","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-020-0075-9","article-title":"Transmission routes of 2019-nCoV and controls in dental practice","volume":"12","author":"Peng","year":"2020","journal-title":"Int. J. Oral Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib48","article-title":"Virucidal activity of different mouthwashes against the salivary load of SARS-CoV-2: a narrative review","volume":"10","author":"Garcia-Sanchez","year":"2022","journal-title":"Healthcare (Basel)"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17701_bib49","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.adaj.2019.06.024","article-title":"Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: a systematic review","volume":"150","author":"Marui","year":"2019","journal-title":"J. Am. Dent. Assoc."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041126","article-title":"COVID-19: a recommendation to examine the effect of mouthrinses with beta-cyclodextrin combined with citrox in preventing infection and progression","volume":"9","author":"Carrouel","year":"2020","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061692","article-title":"Efficacy of pre-procedural mouthwashes against SARS-CoV-2: a systematic review of randomized controlled trials","volume":"11","author":"Garcia-Sanchez","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/jisp.jisp_824_20","article-title":"Chlorhexidine: an effective anticovid mouth rinse","volume":"25","author":"Jain","year":"2021","journal-title":"J. Indian Soc. Periodontol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030272","article-title":"Differential effects of antiseptic mouth rinses on SARS-CoV-2 infectivity in vitro","volume":"10","author":"Xu","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s15010-020-01563-9","article-title":"Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore","volume":"49","author":"Seneviratne","year":"2021","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17701_bib55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.adaj.2021.05.021","article-title":"Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: a randomized controlled trial","volume":"152","author":"Chaudhary","year":"2021","journal-title":"J. Am. Dent. Assoc."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07346","article-title":"Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial","volume":"7","author":"Eduardo","year":"2021","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41591-021-01678-y","article-title":"An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies","volume":"28","author":"VanBlargan","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17701_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"6531","key":"10.1016\/j.heliyon.2023.e17701_bib59","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"Starr","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17701_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17701_bib61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"6523","key":"10.1016\/j.heliyon.2023.e17701_bib62","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo","volume":"370","author":"Hou","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060855","article-title":"Can antiviral activity of licorice help fight COVID-19 infection?","volume":"11","author":"Diomede","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib64","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.antiviral.2009.10.014","article-title":"Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus","volume":"85","author":"Sui","year":"2010","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jep.2013.04.040","article-title":"Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"148","author":"Feng Yeh","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"5733","key":"10.1016\/j.heliyon.2023.e17701_bib66","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/281689a0","article-title":"Glycyrrhizic acid inhibits virus growth and inactivates virus particles","volume":"281","author":"Pompei","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e17701_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1762741","article-title":"Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study","author":"Sinha","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e17701_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26206090","article-title":"Glycyrrhizic acid inhibits SARS-CoV-2 infection by blocking spike protein-mediated cell attachment","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e17701_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105367","article-title":"Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid","volume":"144","author":"Vardhan","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17701_bib70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jmv.25761","article-title":"The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase","volume":"92","author":"Lung","year":"2020","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17701_bib71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7883\/yoken.JJID.2020.902","article-title":"Inactivation of SARS-CoV-2 by catechins from green tea","volume":"74","author":"Nishimura","year":"2021","journal-title":"Jpn. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17701_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26123572","article-title":"Significant inactivation of SARS-CoV-2 in vitro by a green tea catechin, a catechin-derivative, and black tea galloylated theaflavins","volume":"26","author":"Ohgitani","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17701_bib73","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/bib\/bbaa378","article-title":"Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach","volume":"22","author":"Mishra","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.heliyon.2023.e17701_bib74","first-page":"1","article-title":"Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL(pro) from SARS-CoV-2: an integrated in silico approach","author":"Jha","year":"2021","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023049095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023049095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:10:46Z","timestamp":1766171446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023049095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023049095"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17701","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17701"}}